Top Markets
Coin of the day
Xeno Transplants Corporation Xeno Transplants Corporation

Xeno Transplants Corporation

XENO
株式のランク #42146
Xeno Transplants Corporation functions as a biotechnology firm dedicated to... Xeno Transplants Corporation functions as a biotechnology firm dedicated to research and development. Leveraging a specific licensing agreement with Massachusetts General Hospital, the company aims to innovate, produce, commercialize, and implement products and methodologies for public application in the field of xenotransplantation. The primary objective of this xenotransplantation research is to alleviate the critical scarcity of human cells, tissues, and organs required for medical transplants. This is achieved by pioneering techniques that enable the transfer of biological components—such as cells, tissues, and organs—from non-human species, including pigs, into human recipients. Established in 2004, Xeno Transplants Corporation maintains its headquarters in Brookline, Massachusetts.
株価
$0.0001
最終同期: 2026-08-11
時価総額
$4.04K
変化(1日)
0.00%
変化(1年)
0.00%
CA
取引 Xeno Transplants Corporation (XENO)

カテゴリー

Xeno Transplants Corporation(XENO)の配当利回りの履歴
Xeno Transplants Corporation(銘柄コード: XENO)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Xeno Transplants Corporation(XENO)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)